Coronary bypass with sodic danaparold for value replacement during thrombocytopenia due to type II heparin.

Authors
Salmi, L Leroy-Matheron, C LeBesnerais, P Rosanval, O Duvaldestin, P Gouault-Heilmann, M
Citation
L. Salmi et al., Coronary bypass with sodic danaparold for value replacement during thrombocytopenia due to type II heparin., ANN FR A R, 20(9), 2001, pp. 799-802
Citations number
19
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
ISSN journal
07507658 → ACNP
Volume
20
Issue
9
Year of publication
2001
Pages
799 - 802
Database
ISI
SICI code
0750-7658(200111)20:9<799:CBWSDF>2.0.ZU;2-#
Abstract
A type II heparin-induced thrombocytopenia (HIT) was diagnosed in a 64-year -old woman at day 20 of intravenous unfractionated heparin (UFH) therapy, g iven after myocardial infarction treated by angioplasty and intracoronary s tent. The infarction was complicated by a mitral insufficiency that led to a mitral valve replacement. Cardiopulmonary bypass was successfully perform ed with sodium danaparoid (Orgaran((R))), as an alternative to UFH, without thrombotic or haemorragic complications and the follow-up was uneventful. (C) 2001 editions scientifiques et medicales Elsevier SAS.